Controversies in Modern Eye Care meeting set for ophthalmologists, optometrists

Article

One-day continuing education session offers latest insights and advancements.

The Controversies in Modern Eye Care (CIME) meeting is a 1-day event being held April 30, 2023, at the Skirball Cultural Center, Los Angeles, California. Participants may attend in person or virtually.

The emphasis of CIME is to encourage a dialogue between optometrists and ophthalmic surgeons for optimizing patient care.

“The meeting brings together top optometry and surgical experts to share clinical insights and advances in eye care,” according to Neda Shamie, MD, my program cochairperson, and colleague at the Maloney-Shamie Vision Institute in Los Angeles.

For me, this dialogue is all the more important when considering that the number of Americans with impaired vision or blindness is predicted to soar in coming decades as the result of aging and chronic diseases, including diabetes.

It also is important to note that advances in diagnostic tools and treatment choices mean that the nation’s 46,000 optometrists have access to a growing armamentarium of medications and state-of-the-art diagnostic technologies.

The topics to be addressed at the conference include updates in cataract and refractive surgery, postoperative patient care, and choosing the right IOL. Dry and wet labs are scheduled for in-person learners to have hands-on experiences with new devices and equipment.

In addition to ophthalmologists and optometrists, othereye care specialists and health care professionals interested in treating ocular diseases are encouraged to participate.

Those interested can register here. There is no fee for registration at least 30 days in advance of the event.

In-person registration is also available the day of the conference, from 6:30 to 7 AM.

The meeting features great lectures and wet labs with an opportunity to reconnect with old friends.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
© 2024 MJH Life Sciences

All rights reserved.